Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic randomized controlled trial of mesalazine in symptomatic diverticular disease
2006-006198-26Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diverticular disease comparing Mesalazine with Placebo (2 arms). Primary endpoint: Change in galanin expression in mucosal nerves. Started May 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticular disease
Beyond the preview
Go deeper on 2006-006198-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006198-26.